InforMax, Web-based Resources, National Science Grid Projects | GenomeWeb

InforMax Share Price Continues to Fall on News of Poor 2Q Earnings

InforMax shares closed at an all-time low of $0.68 last Thursday following the release of the company’s second-quarter earnings. InforMax reported a 50 percent fall in total 2Q revenue and nearly double the net losses of the year-ago period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.